Surgical management of pituitary adenomas

Singapore Medical Journal

Volumn 43, Issue 6, 2002, Pages 318-323

  Jane Jr , J A ^a   Laws Jr , E R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Acromegaly; Cushing syndrome; Pituitary neoplasm; Prolactinoma; Transsphenoidal surgery

Indexed keywords

ADENOMA; ARTICLE; CUSHING SYNDROME; HUMAN; HYPOPHYSIS TUMOR;

ADENOMA; CUSHING SYNDROME; HUMANS; PITUITARY NEOPLASMS;

EID: 0036598916     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Laws ER, Jane JA, Jr. Pituitary tumors - long-term outcomes and expectations. Clin Neurosurg 2001; 48:306-19.
2. Nishizawa S, Ohta S, Yokoyama T, Uemura K. Therapeutic strategy for incidentally found pituitary tumors ("pituitary incidentalomas"). Neurosurgery 1998; 43:1344-8; discussion 8-50.
3. Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf) 1999; 51:109-13.
4. Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995; 155:181-3.
5. Molitch ME. Pituitary incidentalomas. Endocrinol Metab Clin North Am 1997; 26:725-40.
6. Molitch ME, Russell EJ. The pituitary "incidentaloma" [see comments]. Ann Intern Med 1990; 112:925-31.
7. Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, et al. Factitious Cushing syndrome. J Clin Endocrinol Metab 1996; 81:3573-7.
8. Mengden T, Hubmann P, Muller J, Greminger P, Vetter W, Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Investig 1992; 70:545-8.
9. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34:222-9.
10. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1995; 43:545-50.
11. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 1989; 35:596-600.
12. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB, Jr. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1994; 78:418-22.
13. Flack MR, Oldfield EH, Cutler GB, Jr., Zweig MH, Malley JD, Chrousos GP, et al. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 1992; 116:211-7.
14. Avgerinos PC, Nieman LK, Oldfield EH, Cutler GB, Jr. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome. Clin Endocrinol (Oxf) 1996; 45:483-91.
15. Avgerinos PC, Yanovski JA, Oldfield EH, Nieman LK, Cutler GB, Jr. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. Ann Intern Med 1994; 121:318-27.
16. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB, Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1993; 77:1308-12.
17. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990; 112:434-44.
18. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991; 325:897-905.
19. Trainer PJ, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1991; 34:317-30.
20. Oldfield BH, Girton ME, Doppman JL Absence of intercavernous venous mixing: evidence supporting lateralization of pituitary microadenomas by venous sampling. J Clin Endocrinol Metab 1985; 61:644-7.
21. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, McKeever PE, Krudy AG, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985; 312:100-3.
22. Corrigan DF, Schaaf M, Whaley RA, Czerwinski CL, Earll JM. Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing's syndrome. N Engl J Med 1977; 296:861-2.
23. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120:817-20.
24. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981; 304:156-8.
25. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res 2000; 53:71-5.
26. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001; 48:1239-43; discussion 44-5.
27. Kreutzer J, Vance ML, Lopes MB, Laws ER, Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001; 86:4072-7.
28. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acronegaly. J Clin Endocrinol Metab 1998; 83:2646-52.
29. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM Outcome of surgery for acromegaly the experience of a dedicated pituitary surgeon. QJM 1999; 92:741-5.
30. Swearingen B, Barker FG, 2nd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83:3419-26.
31. Blevins LS, Christy JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 1998; 83:63-7.
32. Yap LB, Turner HE, Adams CB, Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxf) 2002; 56:25-31.
33. Chee GH, Mathias DB, James RA, Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 2001; 54:617-26.
34. Simmons NE, Alden TD, Thorner MO, Laws ER, Jr. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001; 95:1-8.
35. Colao A, Cerbone G, Cappabianca P, Ferone D, Alfieri A, Di Salle F, et al. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998; 21:284-90.
36. Kurosaki M, Ludecke DK, Flitsch J, Saeger W. Surgical treatment of clinically nonsecreting pituitary adenomas in elderly patients. Neurosurgery 2000; 47:843-8; discussion 8-9.